Doxorubicin Induces Inflammatory Modulation and Metabolic Dysregulation in Diabetic Skeletal Muscle

Anti-cancer agent doxorubicin (DOX) has been demonstrated to worsen insulin signaling, engender muscle atrophy, trigger pro-inflammation, and induce a shift to anaerobic glycolytic metabolism in skeletal muscle. The myotoxicity of DOX in diabetic skeletal muscle remains largely unclear. This study e...

Descripción completa

Detalles Bibliográficos
Autores principales: Supriya, Rashmi, Tam, Bjorn T., Pei, Xiao M., Lai, Christopher W., Chan, Lawrence W., Yung, Benjamin Y., Siu, Parco M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961708/
https://www.ncbi.nlm.nih.gov/pubmed/27512375
http://dx.doi.org/10.3389/fphys.2016.00323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961708/
https://www.ncbi.nlm.nih.gov/pubmed/27512375
http://dx.doi.org/10.3389/fphys.2016.00323

Ejemplares similares